Applications of eTag™ assay platform to systems biology approaches in molecular oncology and toxicology studies

Clinical Immunology

Volumn 111, Issue 2, 2004, Pages 162-174

  Chan Hui, P Y ^a   Stephens, K ^a   Warnock, R A ^a   Singh, S ^a  

^a ACLARA BioSciences Inc   (United States)

Author keywords

Gene expression profiling; High throughput screen; Molecular medicine; Molecular oncology; Multiplex assay; Predictive toxicology; Protein expression profiling; Protein phosphorylation; Signal transduction pathway network; Systems biology

Indexed keywords

ABC TRANSPORTER; ALCOHOL DEHYDROGENASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BIOLOGICAL FACTOR; CASPASE 3; CASPASE 7; CATALASE; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; DIHYDROLIPOAMIDE DEHYDROGENASE; DIMETHYLANILINE MONOOXYGENASE; EPOXIDE HYDROLASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN P; GROWTH ARREST AND DNA DAMAGE INDUCIBLE 45 ALPHA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEPATIC NUCLEAR FACTOR 4; INTERLEUKIN 18; METHYLTRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 1; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN; PROTEIN BCL 2; PROTEIN FOS; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOASSAY; CONFERENCE PAPER; DRUG RESEARCH; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOMICS; IMMUNOPRECIPITATION; INTERMETHOD COMPARISON; MASS SPECTROMETRY; NONHUMAN; NUCLEIC ACID ANALYSIS; ONCOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TOXICITY TESTING; TOXICOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MEDICAL ONCOLOGY; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SIGNAL TRANSDUCTION; TOXICOLOGY;

EID: 2342570845     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.12.015     Document Type: Conference Paper

References (78)

1. Simpson R.J., Dorow D.S. Cancer proteomics: from signaling networks to tumor markers. Trends Biotechnol. 19:2001;S40-S48
2. Yaspo M.L. Taking a functional genomics approach in molecular medicine. Trends Mol. Med. 7:2001;494-501
3. Resing K.A. Analysis of signaling pathways using functional proteomics. Ann. N.Y. Acad. Sci. 971:2002;608-614
4. Pauling L.I.H. Sickle cell anemia: a molecular disease. Science. 110:1949;543-548
5. Goessl C. Noninvasive molecular detection of cancer - The bench and the bedside. Curr. Med. Chem. 10:2003;691-706
6. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., Marti G.E., Moore T., Hudson J. Jr., Lu L., Lewis D.B., Tibshirani R., Sherlock G., Chan W.C., Greiner T.C., Weisenburger D.D., Armitage J.O., Warnke R., Staudt L.M., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511
7. Bittner M., Meltzer P., Chen Y., Jiang Y., Seftor E., Hendrix M., Radmacher M., Simon R., Yakhini Z., Ben-Dor A., Sampas N., Dougherty E., Wang E., Marincola F., Gooden C., Lueders J., Glatfelter A., Pollock P., Carpten J., Gillanders E., Leja D., Dietrich K., Beaudry C., Berens M., Alberts D., Sondak V. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 406:2000;536-540
8. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., Borresen-Dale A.L., Brown P.O., Botstein D. Molecular portraits of human breast tumours. Nature. 406:2000;747-752
9. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Eystein Lonning P., Borresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10869-10874
10. Griffin T.J., Gygi S.P., Ideker T., Rist B., Eng J., Hood L., Aebersold R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell Proteomics. 1:2002;323-333
11. Rothenberg M.L., Carbone D.P., Johnson D.H. Opinion: improving the evaluation of new cancer treatments: challenges and opportunities. Nat. Rev., Cancer. 3:2003;303-309
12. Knezevic V., Leethanakul C., Bichsel V.E., Worth J.M., Prabhu V.V., Gutkind J.S., Liotta L.A., Munson P.J., Petricoin E.F. III, Krizman D.B. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics. 1:2001;1271-1278
13. Paweletz C.P., Charboneau L., Bichsel V.E., Simone N.L., Chen T., Gillespie J.W., Emmert-Buck M.R., Roth M.J., Petricoin I.E., Liotta L.A. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene. 20:2001;1981-1989
14. Loda M., Capodieci P., Mishra R., Yao H., Corless C., Grigioni W., Wang Y., Magi-Galluzzi C., Stork P.J. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am. J. Pathol. 149:1996;1553-1564
15. Mandell J.W., Hussaini I.M., Zecevic M., Weber M.J., VandenBerg S.R. In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am. J. Pathol. 153:1998;1411-1423
16. Gioeli D., Mandell J.W., Petroni G.R., Frierson H.F. Jr., Weber M.J. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res. 59:1999;279-284
17. Albanell J., Codony-Servat J., Rojo F., Del Campo J.M., Sauleda S., Anido J., Raspall G., Giralt J., Rosello J., Nicholson R.I., Mendelsohn J., Baselga J. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res. 61:2001;6500-6510
18. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev., Cancer. 2:2002;489-501
19. Land H., Parada L.F., Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 304:1983;596-602
20. Thompson T.C., Southgate J., Kitchener G., Land H. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell. 56:1989;917-930
21. Cazares L.H., Adam B.L., Ward M.D., Nasim S., Schellhammer P.F., Semmes O.J., Wright G.L. Jr. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin. Cancer Res. 8:2002;2541-2552
22. Cash P., Kroll J.S. Protein characterization by two-dimensional gel electrophoresis. Methods Mol. Med. 71:2003;101-118
23. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature. 422:2003;198-207
24. Kalume D.E., Molina H., Pandey A. Tackling the phosphoproteome: tools and strategies. Curr. Opin. Chem. Biol. 7:2003;64-69
25. Unlu M., Morgan M.E., Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis. 18:1997;2071-2077
26. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17:1999;994-999
27. Zhou H., Watts J.D., Aebersold R. A systematic approach to the analysis of protein phosphorylation. Nat. Biotechnol. 19:2001;375-378
28. Oda Y., Nagasu T., Chait B.T. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 19:2001;379-382
29. Goshe M.B., Conrads T.P., Panisko E.A., Angell N.H., Veenstra T.D., Smith R.D. Phosphoprotein isotope-coded affinity tag approach for isolating and quantitating phosphopeptides in proteome-wide analyses. Anal. Chem. 73:2001;2578-2586
30. Ranish J.A., Yi E.C., Leslie D.M., Purvine S.O., Goodlett D.R., Eng J., Aebersold R. The study of macromolecular complexes by quantitative proteomics. Nat. Genet. 33:2003;349-355
31. Hanash S. Disease proteomics. Nature. 422:2003;226-232
32. Paweletz C.P., Ornstein D.K., Roth M.J., Bichsel V.E., Gillespie J.W., Calvert V.S., Vocke C.D., Hewitt S.M., Duray P.H., Herring J., Wang Q.H., Hu N., Linehan W.M., Taylor P.R., Liotta L.A., Emmert-Buck M.R., Petricoin E.F. III Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 60:2000;6293-6297
33. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48:2002;1296-1304
34. Petricoin E.F. III, Ornstein D.K., Paweletz C.P., Ardekani A., Hackett P.S., Hitt B.A., Velassco A., Trucco C., Wiegand L., Wood K., Simone C.B., Levine P.J., Linehan W.M., Emmert-Buck M.R., Steinberg S.M., Kohn E.C., Liotta L.A. Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. 94:2002;1576-1578
35. Rai A.J., Zhang Z., Rosenzweig J., Shih Ie M., Pham T., Fung E.T., Sokoll L.J., Chan D.W. Proteomic approaches to tumor marker discovery. Arch. Pathol. Lab. Med. 126:2002;1518-1526
36. Liotta L., Petricoin E. Molecular profiling of human cancer. Nat. Rev., Genet. 1:2000;48-56
37. MacBeath G. Protein microarrays and proteomics. Nat. Genet. 32:2002;526-532. (Suppl.)
38. Perez O.D., Nolan G.P. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat. Biotechnol. 20:2002;155-162
39. H. Salimi-Moosavi, P.-Y. Chan-Hui, S. Gangakhedkar, J. Wallweber, H. Tahir, H. Kirakossian, S. Singh, Quantitative analysis of protein phosphorylation with multiplex assays and detection by capillary array electrophoresis. Manuscript in preparation (2004).
40. Y. Shi, S. Pidaparthi, R. Dua, H. Kirakossian, P.-Y. Chan-Hui, S. Singh, Simultaneous measurement of dimerization and phosphorylation of epidermal growth factor receptor using proximity-mediated detection of electrophoretic Tags (eTagTM). Manuscript in preparation (2004).
41. Gamett D.C., Pearson G., Cerione R.A., Friedberg I. Secondary dimerization between members of the epidermal growth factor receptor family. J. Biol. Chem. 272:1997;12052-12056
42. Verveer P.J., Wouters F.S., Reynolds A.R., Bastiaens P.I. Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science. 290:2000;1567-1570
43. Castle A.L., Carver M.P., Mendrick D.L. Toxicogenomics: a new revolution in drug safety. Drug Discov. Today. 7:2002;728-736
44. Li A.P. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov. Today. 6:2001;357-366
45. Rushmore T.H., Kong A.N. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 3:2002;481-490
46. Honkakoski P., Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 347:2000;321-337
47. Xu H., el-Gewely M.R. P53-responsive genes and the potential for cancer diagnostics and therapeutics development. Biotechnol. Annu. Rev. 7:2001;131-164
48. Peng H.M., Coon M.J. Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2. Arch. Biochem. Biophys. 382:2000;129-137
49. Rushmore T.H., King R.G., Paulson K.E., Pickett C.B. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. U. S. A. 87:1990;3826-3830
50. Ainbinder E., Bergelson S., Pinkus R., Daniel V. Regulatory mechanisms involved in activator-protein-1 (AP-1)-mediated activation of glutathione-S-transferase gene expression by chemical agents. Eur. J. Biochem. 243:1997;49-57
51. Strom A., Westin S., Eguchi H., Gustafsson J.A., Mode A. Characterization of orphan nuclear receptor binding elements in sex-differentiated members of the CYP2C gene family expressed in rat liver. J. Biol. Chem. 270:1995;11276-11281
52. Bulera S.J., Eddy S.M., Ferguson E., Jatkoe T.A., Reindel J.F., Bleavins M.R., De La Iglesia F.A. RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology. 33:2001;1239-1258
53. Gerhold D., Lu M., Xu J., Austin C., Caskey C.T., Rushmore T. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol. Genomics. 5:2001;161-170
54. Hamadeh H.K., Bushel P.R., Jayadev S., DiSorbo O., Bennett L., Li L., Tennant R., Stoll R., Barrett J.C., Paules R.S., Blanchard K., Afshari C.A. Prediction of compound signature using high density gene expression profiling. Toxicol. Sci. 67:2002;232-240
55. Hamadeh H.K., Bushel P.R., Jayadev S., Martin K., DiSorbo O., Sieber S., Bennett L., Tennant R., Stoll R., Barrett J.C., Blanchard K., Paules R.S., Afshari C.A. Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67:2002;219-231
56. Waring J.F., Jolly R.A., Ciurlionis R., Lum P.Y., Praestgaard J.T., Morfitt D.C., Buratto B., Roberts C., Schadt E., Ulrich R.G. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. 175:2001;28-42
57. Waring J.F., Ciurlionis R., Jolly R.A., Heindel M., Ulrich R.G. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120:2001;359-368
58. Thomas R.S., Rank D.R., Penn S.G., Zastrow G.M., Hayes K.R., Pande K., Glover E., Silander T., Craven M.W., Reddy J.K., Jovanovich S.B., Bradfield C.A. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 60:2001;1189-1194
59. Hellmold H., Nilsson C.B., Schuppe-Koistinen I., Kenne K., Warngard L. Identification of end points relevant to detection of potentially adverse drug reactions. Toxicol. Lett. 127:2002;239-243
60. Kennedy S. The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis. Biomarkers. 7:2002;269-290
61. Wilkins M.R. What do we want from proteomics in the detection and avoidance of adverse drug reactions. Toxicol. Lett. 127:2002;245-249
62. Kocarek T.A., Reddy A.B. Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver. Drug Metab. Dispos. 24:1996;1197-1204
63. Steiner S., Witzmann F.A. Proteomics: applications and opportunities in preclinical drug development. Electrophoresis. 21:2000;2099-2104
64. Enan E., Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem. Pharmacol. 52:1996;1599-1612
65. Berghard A., Gradin K., Pongratz I., Whitelaw M., Poellinger L. Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism. Mol. Cell. Biol. 13:1993;677-689
66. Gradin K., Whitelaw M.L., Toftgard R., Poellinger L., Berghard A. A tyrosine kinase-dependent pathway regulates ligand-dependent activation of the dioxin receptor in human keratinocytes. J. Biol. Chem. 269:1994;23800-23807
67. Chen Y.H., Tukey R.H. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J. Biol. Chem. 271:1996;26261-26266
68. Long W.P., Pray-Grant M., Tsai J.C., Perdew G.H. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol. Pharmacol. 53:1998;691-700
69. Yu R., Jiao J.J., Duh J.L., Tan T.H., Kong A.N. Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1. Cancer Res. 56:1996;2954-2959
70. Yu R., Lei W., Mandlekar S., Weber M.J., Der C.J., Wu J., Kong A.T. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem. 274:1999;27545-27552
71. Davarinos N.A., Pollenz R.S. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytoplasmic proteasome following nuclear export. J. Biol. Chem. 274:1999;28708-28715
72. Pollenz R.S., Barbour E.R. Analysis of the complex relationship between nuclear export and aryl hydrocarbon receptor-mediated gene regulation. Mol. Cell. Biol. 20:2000;6095-6104
73. Chang H.Y., Yang X. Proteases for cell suicide: functions and regulation of caspases. Microbiol. Mol. Biol. Rev. 64:2000;821-846
74. Morishima N., Nakanishi K., Takenouchi H., Shibata T., Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J. Biol. Chem. 277:2002;34287-34294
75. Y. Tan, L. Cao, L. Chen, V. Xaio, T. Matray, S. Moore, A. Chenna, J. Chinn, L. Jiang, A. Inamdar, K.M. Stephens, S. Williams, T. Tian, S. Singh, Predicting drug toxicity using the eTag™ Assay System: a novel high throughput technology platform for simultaneous quantification of gene, protein and activity. Manuscript in preparation (2004).
76. Y. Badel, H. Salimi-Moosavi, X. Jin, H. Tahir, K.M. Stephens, J. Wallweber, T. Dang, H. Kirokossian, S. Singh, Simultaneous analysis of seven cytochrome P450 proteins in cultured primary rat hepatocytes using eTag™ proteomics assay platform. Manuscript in preparation (2004).
77. Matsuda T., Imaoka S., Funae Y., Otori K., Fukushima S. Induction of CYP isoenzymes in various organs of rats by 3-methylcholanthrene or beta-naphthoflavone. Cancer Lett. 97:1995;137-143
78. K.M. Stephens, A. Chenna, H. Kirokossian, S. Singh, Multiplexed and high throughput detection of caspase activities using eTag™ proteomics assay platform. Manuscript in preparation (2004).